Skip to main content
. 2018 Sep 1;10(9):297. doi: 10.3390/cancers10090297

Figure 4.

Figure 4

Summary of select strategies for the therapeutic targeting of mutant p53 in GBM. Approaches include restoration of wild type p53 activity or degradation of mutant p53.